Rainbow Children's Medicare Limited IPO
MainboardHospital & Healthcare Services
Listed On: May 10, 2022 at ₹ 510.0 (NSE)
₹ 14634 /27 Shares
Check AllotmentPrice Summary
Last Closing
1,639.00 (202.4%)52 Week High
1,688.8052 Week Low
1,069.00Last Update
25-Nov-2024 3:30 PMIPO Details
27 Apr, 2022
Open Date29 Apr, 2022
Close Date06 May, 2022
Allotment Date10 May, 2022
Listing DateIssue Price
₹516-542 per equity shareFace Value
₹10 Per Equity ShareListing at Group
BSE, NSERegistrar
KFin Technologies Private LimitedList Price
510.0 (NSE)Listing Date
2022-05-10Market Lot
27 Shares (₹14,634/-)Lead Manager
Kotak Mahindra Capital Company Limited, P. Morgan India Private Limited, IIFL Securities LimitedIssue Size
Total Size : ₹1,564.59 Crores : #Fresh Issue: ₹280 Cr + #Offer for Sale: 24,000,900 SharesRetail Portion
35% (Number of Retail Applications : 3,74,200 Approx)Subscription
12.43 timesIPO Subscription Details
As on | QIB | NII | Retail | Employee | Total |
---|---|---|---|---|---|
Shares Offered / Reserved | 5,775,605 | 4,331,704 | 10,107,308 | 300,000 | 20,514,617 |
Day 1 - 27-04-22 05:00 PM | 0.10 x | 0.12 | 0.48 x | 0.06 x | 0.29 x |
Day 2 - 28-04-22 05:00 PM | 0.10 x | 0.56 | 0.82 x | 0.13 x | 0.55 x |
Day 3 - 29-04-22 05:00 PM | 38.91 x | 3.73 | 1.38 x | 0.31 x | 12.43 x |
Valuations
Earnings Per Share (EPS)
₹3.90/-P/E Ratio
139RoNW
8.88%Net Asset Value (NAV) - As on 31.12.21
₹61.63Company Financials All values are in ₹ Cr.
31-Mar-21 | 31-Mar-20 | 31-Mar-19 | |
---|---|---|---|
Assets | 1,081.26 | 1,019.23 | 926.39 |
Revenue | 660.31 | 729.73 | 551.14 |
Profit After Tax | 39.56 | 55.34 | 44.59 |
About The Company
Rainbow, backed by UK-based development finance institution CDC Group plc, established its first 50-bed pediatric specialty hospital in 1999 in Hyderabad. It is a leading multi-specialty pediatric and obstetrics and gynecology hospital chain in India, operating 14 hospitals and three clinics in six cities, with a total bed capacity of 1,500 beds. Its core specialties are pediatrics, which includes newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care (including multi organ transplants); and obstetrics and gynecology, which includes normal and complex obstetric care, multidisciplinary fetal care, perinatal genetic and fertility care.
It follows a doctor engagement model thus ensuring the availability of most of the specialities available at the firm’s hospital 24/7. In 2021, the firm had 602 full-time doctors and 1,686 part time/visiting doctors. A number of hired doctors in neonatal, pediatric intensive care, pediatric sub specialties, obstetrics and gynaecology are trained or possess qualifications from the United Kingdom, United States, Canada and Australia, which provides the firm with a competitive advantage. The newly hired doctors enter a retainership contract of initial two to three year periods, which provides them with stability and making it a desirable workplace.
The firm plans to increase the scale of its reach to patients through a robust digital ecosystem. The pandemic period, FY 2020-2021, driven in part by the movement restrictions arising out of the COVID-19 pandemic, they conducted over 125,000 outpatient video consultations through video consultation platform including in locations where it does not have a physical presence (within India and abroad).
- Promoter(s)
Pre Issue Share Holding: 62.19%
Post Issue Share Holding: 49.83%
Company Promoter(s)
- Ramesh Kancharla
- Dinesh Kumar Chirla
- Adarsh Kancharla
IPO - Issue Objectives
- Early redemption of non-convertible debentures (NCDs) issued by the company, in full
- Capital expenditure towards setting up of new hospitals
- Purchase of medical equipment for such new hospitals
- General corporate purposes
IPO - Anchor Investors
Investors including Government of Singapore, Monetary Authority of Singapore, Amansa Holdings, Ashoka India Opportunities Fund, Neuberger Berman Emerging Markets, Goldman Sachs, Matthews Emerging Markets Small Companies Fund and HSBC bought equity shares through its anchor book.
Domestic investors also participated in the offer, including Axis Mutual Fund, Nippon Life, IIFL Special Opportunities Fund, HDFC Life Insurance Company, Aditya Birla Sun Life Trustee, DSP Mutual Fund, Baroda BNP Paribas Multi Cap Fund, Motilal Oswal MF, UTI MF, and Max Life Insurance.
IPO - FAQs
Ans. Rainbow Children's Medicare Limited IPO is a Mainboard IPO. The issue is priced at ₹516-542 per equity share. The minimum order quantity is 27 Shares. The IPO opens on Apr 27, 2022, and closes on Apr 29, 2022. KFin Technologies Private Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Ans. The Rainbow Children's Medicare Limited IPO opens on Apr 27, 2022 and closes on Apr 29, 2022.
Ans. The size of Rainbow Children's Medicare Limited IPO is Total Size : ₹1,564.59 Crores : #Fresh Issue: ₹280 Cr + #Offer for Sale: 24,000,900 Shares.
Ans. The IPO price band is set between ₹516-542 per equity share.
Ans. To apply for Rainbow Children's Medicare Limited IPO IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Rainbow Children's Medicare Limited IPO in the List of IPOs
- - Press "Apply" Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Rainbow Children's Medicare Limited IPO is May 6, 2022.
Ans. The Rainbow Children's Medicare Limited IPO will be listed on May 10, 2022.
Ans. Follow the steps to check the allotment status for Rainbow Children's Medicare Limited IPO here.